Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Tumor antigens BFA4 and BCY1 for prevention and / or treatment of cancer

Tumor antigens BFA4 and BCY1 for prevention and / or treatment of cancer

US Patent 7851213 · Granted Dec 14, 2010

Estimated economic value: $5,381,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Engineered influenza antigenic polypeptides and immunogenic compositions thereof2024
Programmed death 1 ligand 1 (PD-L1) binding proteins and methods of use thereof2024
Modification of engineered influenza hemagglutinin polypeptides2024
Methods of generating broadly protective vaccine compositions comprising hemaggl2023
Enhanced expansion of tumor-infiltrating lymphocytes for adoptive cell therapy2022
Engineered influenza antigenic polypeptides and immunogenic compositions thereof2022
Programmed death 1 ligand 1 (PD-L1) binding proteins and methods of use thereof2021
Modification of engineered influenza hemagglutinin polypeptides2021
Method for improving the efficacy of a survivin vaccine in the treatment of canc2020
Engineered influenza antigenic polypeptides and immunogenic compositions thereof2020
Method for improving the efficacy of a survivin vaccine in the treatment of canc2018
Immunogenic compositions and related methods2017